Journal profile · Medicine-Public Health, Environmental and Occupational Health
Infectious Diseases Immunity
ISSN 2096-9511 · eISSN 2693-8839 · Wolters Kluwer Health - Lippincott Williams Wilkins · United States
Infectious Diseases Immunity: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.7 (journal website); JCR Q2 (journal website); diamond open access (no APC); no APC; median 103 days to acceptance (52 articles, last 24 months); 47 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Infectious Diseases Immunity is published by Wolters Kluwer Health - Lippincott Williams Wilkins and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Hepatitis B Virus Studies, together about 30.3% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Infectious Diseases & Immunity (IDI) is an international, peer-reviewed, open access journal. It is supervised by Chinese Association for Science and Technology, sponsored by Chinese Medical Association, and published in collaboration with Wolters Kluwer. The Editor-in-Chief, Professor Fu-Sheng Wang, a member of the Chinese Academy of Sciences, works with the editorial board closely.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Public Health, Environmental and Occupational Health
Editor-in-chief Fu-Sheng WangPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine12.6%
- SARS-CoV-2 and COVID-19 ResearchMedicine10.6%
- Hepatitis B Virus StudiesMedicine7.1%
- HIV Research and TreatmentImmunology and Microbiology6.3%
- Liver Disease Diagnosis and TreatmentMedicine5.7%
- Hepatitis C virus researchMedicine4.9%
- Long-Term Effects of COVID-19Medicine4.6%
- HIV/AIDS Research and InterventionsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · INFECTIOUS DISEASES · rank 44/141
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.7Publisher website ·
- CiteScore 2026-06
- 1.4LetPub ·
- SJR 2026-06
- 0.25LetPub ·
- SNIP 2026-06
- 0.19LetPub ·
- h-index
- 11OpenAlex ·
- i10-index
- 13OpenAlex ·
- 2-year mean citedness
- 1.93OpenAlex ·
- Self-citation rate
- 2.7%LetPub ·
- Share of gold OA articles
- 96.05%LetPub ·
Volume
- Articles per year
- 30LetPub ·
Articles by year OpenAlex count · 221 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 23 | 23 | 0 |
| 2025 | 47 | 47 | 56 |
| 2024 | 50 | 50 | 176 |
| 2023 | 22 | 22 | 30 |
| 2022 | 39 | 39 | 156 |
| 2021 | 40 | 40 | 179 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
103 daysMedian, submission to acceptance · P25–P75 75 days – 152 days
- Acceptance to online
- median 21 days (52 articles)
- Submission to online
- median 131 days
- Sample
- 52 articles with submission and acceptance dates (83 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Submission to publication (journal-reported)
- about 9 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 500 words
- Keywords
- 3–6
- Cover letter
- Required
Article types accepted7, with length limits
- commentaryType Text* Word count Abstract Word count Figures/Tables References Supplement possible Editorial 1500 No abstract 1 20 No Consensus & Guideline No requirements…Length not stated
- correspondenceType Text* Word count Abstract Word count Figures/Tables References Supplement possible Editorial 1500 No abstract 1 20 No Consensus & Guideline No requirements…Length not stated
- editorialType Text* Word count Abstract Word count Figures/Tables References Supplement possible Editorial 1500 No abstract 1 20 No Consensus & Guideline No requirements…Length not stated
- original articleType Text* Word count Abstract Word count Figures/Tables References Supplement possible Editorial 1500 No abstract 1 20 No Consensus & Guideline No requirements…Length not stated
- perspectiveType Text* Word count Abstract Word count Figures/Tables References Supplement possible Editorial 1500 No abstract 1 20 No Consensus & Guideline No requirements…main text ≤ 1,500 words
- protocolType Text* Word count Abstract Word count Figures/Tables References Supplement possible Editorial 1500 No abstract 1 20 No Consensus & Guideline No requirements…Length not stated
- reviewType Text* Word count Abstract Word count Figures/Tables References Supplement possible Editorial 1500 No abstract 1 20 No Consensus & Guideline No requirements…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- AI use Generative AI
Authors are fully responsible for the content of their manuscript, even those parts produced by GenAI. Authors who have used GenAI in their research and the writing of manuscripts should provide an open, transparent, and detailed description of the use of GenAI (including the name and version of the GenAI tool, when it was used, how it was used, and the process of using it, and, if necessary, anno…
Source ↗Publisher website ·- Authorship Authorship
IDI expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.
Source ↗Publisher website ·- Conflicts of interest Disclosure of Conflicts
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources …
Source ↗Publisher website ·- Data availability Data Availability Statement
IDI requires authors to include a Data Availability Statement in any articles that report results derived from research data, from Jan 2023. The provision of a Data Availability Statement will be verified as a condition of publication. Data Availability Statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyper…
Source ↗Publisher website ·- License & copyright Copyright
The Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal.
Source ↗Publisher website ·- Open access Open Access
Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs. The Chinese Medi…
Source ↗Publisher website ·- Peer review Peer Review
IDI operates a double-blind external peer review process, where in the reviewers and authors are unaware of each other’s identity. Brief introduction on editorial review process of the journal:
Source ↗Publisher website ·- Plagiarism Plagiarism
As defined by the World Association of Medical Editors (https://www.wame.org/resources):
Source ↗Publisher website ·- Trial registration / reporting guidelines Other Reporting Guidelines
The following reporting guidelines need to be followed by authors:
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health - Lippincott Williams Wilkins
- Country or region
- United States
- Language
- English
- ISSN
- 2096-9511
- Electronic ISSN
- 2693-8839
- Society / sponsor
- Wolters Kluwer
- Latest issue on the website
- Volume 6, Issue 3 (July 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Infectious Diseases Immunity
What CAS zone is Infectious Diseases Immunity in?
In the 2025 upgraded edition of the CAS Journal Ranking, Infectious Diseases Immunity is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Infectious Diseases Immunity?
The journal's website gives an impact factor of 3.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.4, h-index 11.
How long does peer review take at Infectious Diseases Immunity?
Based on the dates recorded on 52 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 103 days (interquartile range 75–152 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Infectious Diseases Immunity in?
The journal's website gives JCR Q2; by category, INFECTIOUS DISEASES Q2 (44/141). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
What are the manuscript requirements of Infectious Diseases Immunity?
According to the journal's author guidelines: Abstract: ≤ 500 words; Keywords: 3–6; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Infectious Diseases Immunity?
According to LetPub and DOAJ records, Infectious Diseases Immunity is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC and Embase; that list has not been checked against each database.
Is Infectious Diseases Immunity open access, and what is the APC?
Infectious Diseases Immunity is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .